Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christopher Peetz Insider Profile
11 Followers
Christopher Peetz, CFO at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 335.35K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 0.00 shares in Alpine Immune Sciences (Ticker: ALPN). Most recently, Christopher Peetz ― shares of Tobira Therapeutics on ― for an estimated value of ―.
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
-4.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Peetz's holdings
Insider Roles
CEO, Director
Roles that Christopher Peetz holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 10, 2019 - Sep 10, 2020
Return:+91.90%
The most profitable trade made by Christopher Peetz
Christopher Peetz's Trading History
Tobira Therapeutics
―
―
―
$0.00
Alpine Immune Sciences
May 20, 2024
―
Uninformative Sell
―
$0.00
Mirum Pharmaceuticals
Jul 24, 2024
CEO, Director
Uninformative Buy
99.66K
$14.08M
List of latest transactions for each holding click on a transaction to see Christopher Peetz's performance on stock
You May Also Like
Christopher Peetz insider profile FAQ
What is the percentage of profitable transactions made by Christopher Peetz?
The percentage of profitable transactions made by Christopher Peetz is 44%.
What is the average return per transaction made by Christopher Peetz?
The average return per transaction made by Christopher Peetz is -4.90%.
What stocks does Christopher Peetz hold?
Christopher Peetz holds: TBRA, ALPN, MIRM stocks.
What was Christopher Peetz’s latest transaction?
Christopher Peetz latest transaction was an Uninformative Buy of ―.
What was Christopher Peetz's most profitable transaction?
Christopher Peetz’s most profitable transaction was an Informative Buy of MIRM stock on September 10, 2019. The return on the trade was 91.90%.
What is Christopher Peetz's role in Tobira Therapeutics?
Christopher Peetz's role in Tobira Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.